Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE: DNA · Real-Time Price · USD

Compare

8.27

-0.52 (-5.92%)

At close: Feb 4, 2026, 4:00 PM EST

8.43

+0.16 (1.93%)

After-hours: Feb 4, 2026, 7:56 PM EST

Ginkgo Bioworks Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	111.07	561.57	944.07	1,316	1,550	380.8
Cash & Short-Term Investments	461.86	561.57	944.07	1,316	1,550	380.8
Cash Growth	-25.05%	-40.52%	-28.25%	-15.11%	307.04%	-23.11%
Accounts Receivable	22.36	22.44	17.9	82.47	136.14	21.91
Other Receivables	-	-	-	1.56	-	-
Receivables	22.36	22.44	30.19	84.03	147.7	24.17
Inventory	-	-	-	4.36	3.51	9.27
Prepaid Expenses	13.06	12.89	22.7	35.11	18.94	10.85
Restricted Cash	8.8	5.84	4.79	8.22	-	-
Other Current Assets	-	-	-	2.57	2.9	1.44
Total Current Assets	506.08	602.74	1,002	1,450	1,723	426.54
Property, Plant & Equipment	544.79	598.16	394.99	718.79	145.77	121.44
Long-Term Investments	30.18	48.7	78.57	113.73	115.23	103.12
Goodwill	-	-	49.24	60.21	21.31	1.86
Other Intangible Assets	61.52	72.51	82.74	111.04	21.64	3.29
Other Long-Term Assets	39.47	41.17	44.45	47.81	43.99	5.6
Total Assets	1,189	1,377	1,665	2,539	2,071	675.15
Accounts Payable	10.7	14.17	9.32	10.45	8.19	13.89
Accrued Expenses	52.5	19.19	49.87	52.3	85.14	17.73
Current Portion of Leases	-	28.97	17.47	29.33	0.75	0.49
Current Unearned Revenue	25.24	30.6	48.5	47.82	33.24	28.82
Other Current Liabilities	26.84	14.34	38.7	33.06	7.45	12.29
Total Current Liabilities	115.28	107.27	163.86	172.96	134.76	73.22
Long-Term Leases	422.87	438.79	221.84	413.26	22.28	16.52
Long-Term Unearned Revenue	74.07	98.78	158.06	174.77	155.99	99.65
Other Long-Term Liabilities	17.16	16.55	24.43	42.06	190.58	15.71
Total Liabilities	629.38	661.39	568.19	803.04	503.61	205.1
Common Stock	0.01	0.01	0.01	0.19	0.16	0.13
Additional Paid-In Capital	6,627	6,555	6,386	6,136	3,805	929.13
Retained Earnings	-6,070	-5,838	-5,291	-4,398	-2,298	-467.88
Comprehensive Income & Other	2	-1.81	1.48	-2.63	-1.72	-
Total Common Equity	559.78	716.06	1,097	1,736	1,505	461.38
Minority Interest	-	-	-	-	62.01	8.68
Shareholders' Equity	559.78	716.06	1,097	1,736	1,567	470.05
Total Liabilities & Equity	1,189	1,377	1,665	2,539	2,071	675.15
Total Debt	422.87	467.76	239.31	442.59	23.03	17
Net Cash (Debt)	38.99	93.82	704.76	873.2	1,527	363.8
Net Cash Growth	-77.15%	-86.69%	-19.29%	-42.81%	319.73%	-23.88%
Net Cash Per Share	0.71	1.81	14.50	20.79	44.90	11.42
Filing Date Shares Outstanding	56.84	54.37	50.03	51.81	43.99	7.85
Total Common Shares Outstanding	56.84	54.37	50.03	47.3	40.28	7.85
Working Capital	390.8	495.48	837.89	1,277	1,588	353.32
Book Value Per Share	9.85	13.17	21.93	36.71	37.37	58.77
Tangible Book Value	498.26	643.55	965.17	1,565	1,462	456.23
Tangible Book Value Per Share	8.77	11.84	19.29	33.09	36.30	58.11
Land	6.06	6.06	6.06	6.06	-	-
Buildings	49.76	48.26	47.03	-	-	-
Machinery	162.32	172.33	168.42	206.72	128.75	56.14
Construction In Progress	-	1.98	15.83	23.43	10.28	42.58
Leasehold Improvements	140.51	135.96	71.56	125.31	55.03	40.44

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q